By contrast, fatty liver — once called nonalcoholic fatty ... with CT as the second-best choice, Petrov said. In countries where advanced imaging is not available, a low-cost alternative might ...

Those in favor of the classification argue that excess fat accumulation/distribution is linked to sustained and serious ...

It was only a matter of time until the GLP-1 receptor agonist drugs like Ozempic and Wegovy were superseded, and now it looks ...

A live webcast of the Leerink presentation may be accessed via a link on the Viking Therapeutics website in the Investors & Media section under Webcasts. Additionally, a replay of the webcast will ...

Viking Therapeutics, Inc. ("Viking") , a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced the completion of ...

Investigating GLP-1 RAs reveals their impact on women's health, addressing metabolic disorders, reproductive health, and ...

GUANGDONG, China and BAGSVAERD, Denmark I March 24, 2025 IThe United Laboratories International Holdings Limited (TUL) and Novo Nordisk A/S (Novo Nordisk) ...

World Health Day is just around the corner, which means it's the perfect time to explore some products that can potentially ...

"We are excited to enter into this agreement with one of the world's leading CDMOs in the peptide space," said ... for the treatment of non-alcoholic fatty liver disease (NAFLD) and elevated ...

Weight loss drugs have surged in popularity. But Gov. Ned Lamont wants CT’s Medicaid program to discontinue covering them for ...

From collagen peptides to cholesterol supplements, this guide aims to have you covered with products that could elevate body, ...

Understanding fiber's role in nutrition reveals its potential in preventing chronic diseases, improving gut health, and reducing colorectal cancer risk.